Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

PMID:
24450891
2.

Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.

Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM.

Neurobiol Aging. 2012 Mar;33(3):457-65. doi: 10.1016/j.neurobiolaging.2010.04.018.

PMID:
20570408
3.

An exploration of cognitive subgroups in Alzheimer's disease.

Davidson JE, Irizarry MC, Bray BC, Wetten S, Galwey N, Gibson R, Borrie M, Delisle R, Feldman HH, Hsiung GY, Fornazzari L, Gauthier S, Guzman D, Loy-English I, Keren R, Kertesz A, George-Hyslop PS, Wherrett J, Monsch AU.

J Int Neuropsychol Soc. 2010 Mar;16(2):233-43. doi: 10.1017/S1355617709991160.

PMID:
19958568
4.

Differentiating the frontal variant of Alzheimer's disease.

Woodward M, Jacova C, Black SE, Kertesz A, Mackenzie IR, Feldman H; ACCORD investigator group..

Int J Geriatr Psychiatry. 2010 Jul;25(7):732-8. doi: 10.1002/gps.2415.

PMID:
19823987
5.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003.

PMID:
19013250
6.

Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.

Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH.

Dement Geriatr Cogn Disord. 2008;25(6):483-90. doi: 10.1159/000126499.

PMID:
18417973
7.

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-English I, Matthews PM, Owen MJ, Plumpton M, Pryse-Phillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, St George-Hyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD.

Arch Neurol. 2008 Jan;65(1):45-53.

PMID:
17998437
8.

Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals.

Peters KR, Rockwood K, Black SE, Hogan DB, Gauthier SG, Loy-English I, Hsiung GY, Jacova C, Kertesz A, Feldman HH.

Am J Geriatr Psychiatry. 2008 Feb;16(2):136-44.

PMID:
17928572
9.

Gender differences in dementia risk factors.

Azad NA, Al Bugami M, Loy-English I.

Gend Med. 2007 Jun;4(2):120-9. Review.

PMID:
17707846
10.

Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.

Hsiung GY, Donald A, Grand J, Black SE, Bouchard RW, Gauthier SG, Loy-English I, Hogan DB, Kertesz A, Rockwood K, Feldman HH.

Dement Geriatr Cogn Disord. 2006;22(5-6):413-20.

PMID:
16966831
11.

Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.

Peters KR, Rockwood K, Black SE, Bouchard R, Gauthier S, Hogan D, Kertesz A, Loy-English I, Beattie BL, Sadovnick AD, Feldman HH.

Neurology. 2006 Feb 28;66(4):523-8.

PMID:
16505306
12.

Predictors of seizure outcome following cortical resection in pediatric and adolescent patients with medically refractory epilepsy.

Gashlan M, Loy-English I, Ventureyra EC, Keene D.

Childs Nerv Syst. 1999 Jan;15(1):45-50; discussion 50-1.

PMID:
10066019
13.

Long-term socioeconomic outcome following surgical intervention in the treatment of refractory epilepsy in childhood and adolescence.

Keene DL, Loy-English I, Ventureyra EC.

Childs Nerv Syst. 1998 Aug;14(8):362-5.

PMID:
9753401
14.

Patient satisfaction with surgical treatment of refractory epilepsy done in childhood and early adolescence.

Keene DL, Loy-English I, Ventureyra EC.

Childs Nerv Syst. 1998 Jan-Feb;14(1-2):30-2.

PMID:
9548337
Items per page

Supplemental Content

Loading ...
Support Center